Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55
15/05/2024 21:00
May 15 (Reuters) - VBI Vaccines Q1 operating expenses USD 12.966 million. * Q1 operating income USD -11.752 million * Q1 adjusted net income USD -13.57 million * Q1 revenue USD 1.214 million * Q1 net income USD -17.9 million
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55